America Pouchitis Treatment Market – Synopsis

Pouchitis is one of the most common complications of ileal pouch-anal anastomosis (IPAA) surgery and has a significant adverse impact on the quality of life. Pouchitis is an inflammation of the surgically constructed pouch.

Request for Sample Report at https://www.marketresearchfuture.com/sample_request/5254

Various therapies are recommended for the treatment of pouchitis such as antibiotics, budesonide enemas, probiotics, probiotics, butyrate suppositories, bismuth enemas, and others. The America pouchitis treatment market is expected to grow at a CAGR of 8.34% during the forecast period 2017-2023.

Increasing need for ileal pouch-anal anastomosis procedure, long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs), rising prevalence of ulcerative colitis (UC), and increasing geriatric population are the key factors driving the pouchitis treatment market.

America Pouchitis Treatment Market - Segmentation:

The America pouchitis treatment market is segmented on the basis of treatment and end user.

On the basis of the treatment, the market is segmented into antibiotics, probiotics, and others. The antibiotic segment is further sub-segmented into ciprofloxacin, metronidazole, rifaximin, and others.

On the basis of the end -users, the market is segmented into hospitals & clinics, research institutes, and others.

Around 30% of patients with ulcerative colitis (UC) undergo colectomy with ileal pouch-anal anastomosis (IPAA) surgery and up to 50% of patients develop at least one episode of pouchitis. So, rising prevalence of ulcerative colitis is boosting the Americas pouchitis treatment market. According to the Centres for Disease Control and Prevention, in 2015, around 1.3% of the U.S. adults were diagnosed with inflammatory bowel disease (IBD). The prevalence of ulcerative colitis is reported to be 37 to 246 cases per 100,000 individuals whereas, the incidence rate is found to be 2.2 to 14.3 cases per 100,000 person-years.

America Pouchitis Treatment Market - Key Players:

Pfizer
Abbott
Allergan Plc
Bayer
Alfa sigma
Atlantic Healthcare
Tillotts Pharma etc.
Ask Any Question at https://www.marketresearchfuture.com/enquiry/5254

America Pouchitis Treatment Market - Regional Analysis:

On the basis of region, the America pouchitis treatment market is segmented into North America, and South America. North America accounts for a major share owing to the rising cases of pouchitis, and high healthcare expenditure. People in this region are more inclined towards quality healthcare that leads to increase in the healthcare spending. Due to rising prevalence of pouchitis, various companies, private organizations, and government associations are also actively participating to improve the treatment options.

The Americas pouchitis market is driven by ongoing extensive research in the inflammatory bowel disease (IBD). The American Gastroenterological Association (AGA) has introduced several new research grants to support investigators studying inflammatory bowel disease (IBD) such as Takeda Pharmaceuticals research scholar awards in IBD, and Pfizer pilot research award in IBD.

Major TOC of America Pouchitis Treatment Market Research Report-Forecast till 2023:

1 Report Prologue

2 Market Introduction

3 Research Methodology

4 Market Factor Analysis

5 Market Dynamics

6 Americas pouchitis treatment market by Treatment

7 Americas pouchitis treatment market by End User

8 Americas pouchitis treatment market by Region

9 Company Landscape

10 Company Profiles

Check Discount at https://www.marketresearchfuture.com/check-discount/5254

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: [email protected]